Stocks to watch on September 24: Dr Lal PathLabs, Nykaa, Vedanta among those in focus

Dr Lal PathLabs said it will acquire a 70% stake in SN Genelab Private Limited for up to ₹168 crore, with an additional earn-out of ₹31.5 crore possible, making SN Gene a subsidiary after the deal.

LCC Projects emerged as the L-1 bidder for the ₹653.34 crore Chhoti Kalisindh Medium Irrigation Project in Rajasthan, which involves building a sprinkler-based irrigation system with solar power components.

Vedanta clarified that its ESOS 2026 scheme is fully performance-linked, with no time-based or guaranteed vesting, and said it will provide enhanced disclosures in future annual reports.

Sterlite Technologies announced an expansion of its Neuralis Data Center portfolio with pre-terminated fiber trunk assemblies ranging from 48F to 6,912F.

Nykaa and BOLD, L’Oréal’s corporate venture capital fund, announced a collaboration to jointly invest in high-growth Indian beauty and personal care brands.

JSW Cement received a show cause notice from the Central Tax department over alleged short payment of GST due to incorrect classification, with a proposed demand of ₹229.85 crore for April 2022–March 2024, plus interest and a 10% penalty.

Nava said its step-down subsidiary Maamba Solar Energy has commissioned a 100 MW solar power plant in Zambia, with power evacuation to the Zambian grid now underway.

Mayasheel Ventures secured a ₹17.94 crore work order from A T Infracon for the manufacture, supply, erection, and delivery of precast RCC box culverts in the Jammu sector.

Mahindra & Mahindra Financial Services’ Debenture Issuance Committee approved the issuance of up to ₹2,000 crore of secured, rated, listed, and redeemable non-convertible debentures through private placement.

During Thursday’s trading session, the Nifty 50 fell 1.64% to close at 25,169.50, while the Sensex ended at 73,580, down 1.67%. The Nifty Midcap 100 dropped 2.57% and the Nifty Smallcap 100 declined 2.25%, with the financial sector among the worst performers after IRDAI proposed changes to insurance commission rules.